Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-06-30 View official record Methodology

Covered recipient · General Payments record

EMMANUEL JEAN-MARIE MIGNOT

Allopathic & Osteopathic Physicians Psychiatry & Neurology Sleep Medicine

NPI
1023151800
CMS profile
961917
Location
STANFORD, CA

General Payments · PY2019–2025

$134,564.03

  • Reported across 95 records
  • CMS publication 2026-06-30

Latest program year · PY2025

$47,971.34

26 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2025 · sorted by reported total

By paying entity

PY2025 · sorted by reported total

Paying entityAmountRecords
Takeda Pharmaceuticals U.S.A., Inc. $27,549.24 14
Avadel CNS Pharmaceuticals, LLC $11,180.09 3
Alkermes, Inc. $4,743.27 5
EISAI INC. $3,000.00 1
SANOFI US SERVICES INC. $1,324.00 1
JAZZ PHARMACEUTICALS INC. $137.65 1
Axsome Therapeutics, Inc. $37.09 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,292.12 9
PY2020 $14,160.00 5
PY2021 $23,131.44 17
PY2022 $2,844.54 7
PY2023 $4,565.65 9
PY2024 $40,598.94 22
PY2025 $47,971.34 26

Payment records · PY2025 (26)

Sorted by paying entity, then date · as published by CMS

Program year 2025 201920202021202220232024 Record-level detail is published for PY2025; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Alkermes, Inc. $19.16 09/20/2025 Food and Beverage Undisputed 06/30/2026 1222569486 CMS
Alkermes, Inc. $59.11 09/20/2025 Food and Beverage Undisputed 06/30/2026 1222569488 CMS
Alkermes, Inc. $1,650.00 10/06/2025 Consulting Fee Undisputed 06/30/2026 1223443582 CMS
Alkermes, Inc. $1,340.00 10/14/2025 Consulting Fee Undisputed 06/30/2026 1223443584 CMS
Alkermes, Inc. $1,675.00 11/24/2025 Consulting Fee Undisputed 06/30/2026 1222569494 CMS
Avadel CNS Pharmaceuticals, LLC $3,815.00 01/15/2025 Consulting Fee Undisputed 06/30/2026 1208538510 CMS
Avadel CNS Pharmaceuticals, LLC $7,325.81 01/15/2025 Travel and Lodging Undisputed 06/30/2026 1208538512 CMS
Avadel CNS Pharmaceuticals, LLC $39.28 01/21/2025 Food and Beverage Undisputed 06/30/2026 1208538514 CMS
Axsome Therapeutics, Inc. $37.09 06/10/2025 Food and Beverage Undisputed 06/30/2026 1235300749 CMS
Eisai Inc. $3,000.00 06/04/2025 Consulting Fee Undisputed 06/30/2026 1244478304 CMS
JAZZ PHARMACEUTICALS INC. $137.65 06/08/2025 Food and Beverage Undisputed 06/30/2026 1234305277 CMS
SANOFI US SERVICES INC. $1,324.00 07/02/2025 Consulting Fee Undisputed 06/30/2026 1233456988 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,895.00 01/03/2025 Consulting Fee Undisputed 06/30/2026 1223793497 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,895.00 01/03/2025 Consulting Fee Undisputed 06/30/2026 1223793499 CMS
Takeda Pharmaceuticals U.S.A., Inc. $10,422.00 02/07/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 06/30/2026 1223795110 CMS
Takeda Pharmaceuticals U.S.A., Inc. $65.62 03/14/2025 Food and Beverage Undisputed 06/30/2026 1223944370 CMS
Takeda Pharmaceuticals U.S.A., Inc. $3,000.00 05/09/2025 Consulting Fee Undisputed 06/30/2026 1223792304 CMS
Takeda Pharmaceuticals U.S.A., Inc. $106.66 05/20/2025 Food and Beverage Undisputed 06/30/2026 1223943339 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2.21 05/21/2025 Food and Beverage Undisputed 06/30/2026 1223941865 CMS
Takeda Pharmaceuticals U.S.A., Inc. $86.93 06/07/2025 Food and Beverage Undisputed 06/30/2026 1223944464 CMS
Takeda Pharmaceuticals U.S.A., Inc. $6,300.00 07/25/2025 Consulting Fee Undisputed 06/30/2026 1223793635 CMS
Takeda Pharmaceuticals U.S.A., Inc. $78.20 08/18/2025 Food and Beverage Undisputed 06/30/2026 1223944438 CMS
Takeda Pharmaceuticals U.S.A., Inc. $73.12 08/19/2025 Food and Beverage Undisputed 06/30/2026 1223943095 CMS
Takeda Pharmaceuticals U.S.A., Inc. $34.84 09/20/2025 Food and Beverage Undisputed 06/30/2026 1223942679 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,500.00 11/07/2025 Consulting Fee Undisputed 06/30/2026 1223787615 CMS
Takeda Pharmaceuticals U.S.A., Inc. $89.66 11/11/2025 Food and Beverage Undisputed 06/30/2026 1223943301 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.